연구성과로 돌아가기

2020 연구자 정보 (39 / 997)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, Y.
(Kim, Y)
Kyungpook Natl Univ, Internal Med, Daegu, South Korea
Keimyung Univ Dongsan Hosp, Internal Med, Daegu, South Korea
Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Korea Univ, Seoul 02841, South Korea
Yonsei Univ, Seoul 120749, South Korea
JRX-0407-2023
AAU-5043-2020
Kim, Bo-Hyung
Kim, Ji

[JCR상위 2.6] Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients
[JCR상위 2.6] Time-Trend of Metabolic Risks in Living Kidney Donors in South Korea
[JCR상위 2.6] Assessment of the Usefulness of Urine Signature to Differentiate Acute Rejection in a Prospective Kidney Transplantation Cohort
[JCR상위 14.7] The efficacy and safety of adalimumab for patients with moderately to severely active ulcerative colitis and predictors of response in Korea
[JCR상위 7.6] Search for an Invisibly Decaying Z′ Boson at Belle II in e⁺e⁻ → μ⁺μ⁻ (e±μ∓) Plus Missing Energy Final States
[JCR상위 44.7] Measurement of the integrated luminosity of the Phase 2 data of the Belle II experiment
[JCR상위 42.4] The Belle II Physics Book (Dec, 10.1093/ptep/ptz106, 2019)
SCIE 2.6 SURGERY;TRANSPLANTATION
GASTROENTEROLOGY & HEPATOLOGY
PHYSICS, MULTIDISCIPLINARY
PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS
PHYSICS, MULTIDISCIPLINARY;PHYSICS, PARTICLES & FIELDS
kou@lal.in2p3.fr;
Lim, J.
(Lim, J)
Kyungpook Natl Univ, Internal Med, Daegu, South Korea

[JCR상위 2.6] Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients SCIE 2.6 SURGERY;TRANSPLANTATION
Moon, J.
(Moon, J)
Kyung Hee Univ Hosp Gangdong, Div Nephrol, Dept Internal Med, Seoul, South Korea
Kangwon Natl Univ Hosp, Prevent Med, Chunchon, South Korea
Gangwon Reg Cardiocerebrovasc Dis Ctr, Prevent & Management Ctr, Chunchon, South Korea


[JCR상위 2.6] Assessment of the Usefulness of Urine Signature to Differentiate Acute Rejection in a Prospective Kidney Transplantation Cohort
[JCR상위 19.2] QUALITY OF LIFE AND ASSOCIATED FACTORS AMONG STROKE PATIENTS IN KOREA: FROM 1 YEAR OUTPATIENT FOLLOW UP AFTER ATTACK
SCIE 2.6 SURGERY;TRANSPLANTATION
CLINICAL NEUROLOGY;PERIPHERAL VASCULAR DISEASE
Noh, H.
(Noh, H)
Kyungpook Natl Univ, Internal Med, Daegu, South Korea

[JCR상위 2.6] Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients SCIE 2.6 SURGERY;TRANSPLANTATION
Park, Hyeona
(Park, H)
Kyungpook Natl Univ, Dept Environm Engn, 80 Daehak Ro, Daegu 41566, South Korea

[JCR상위 2.6] Hybrid electrochemical microfiltration treatment of reverse osmosis concentrate: A mechanistic study on the effects of electrode materials
[JCR상위 2.5] Highly robust and efficient Ti-based Sb-SnO2 anode with a mixed carbon and nitrogen interlayer for electrochemical 1,4-dioxane removal from water
SCIE 2.5 ENGINEERING, CHEMICAL;WATER RESOURCES
ENGINEERING, CHEMICAL;ENGINEERING, ENVIRONMENTAL
chookh@knu.ac.kr;
Seo, J.
(Seo, J)
제1저자 Kyung Hee Univ Hosp Gangdong, Med Sci Inst, Dept Core Res Lab, Seoul, South Korea

[JCR상위 2.6] Assessment of the Usefulness of Urine Signature to Differentiate Acute Rejection in a Prospective Kidney Transplantation Cohort SCIE 2.6 SURGERY;TRANSPLANTATION
Ahn, J. B.
(Ahn, JB)
Severance Hosp, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea

[JCR상위 2.7] Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study SCIE 2.7 ONCOLOGY
Ahn, M-J.
(Ahn, MJ)
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr SMC, Dept Med, Seoul, South Korea

[JCR상위 2.7] Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) SCIE 2.7 ONCOLOGY
Amero, Paola
(Amero, P)
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA

[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Anfossi, Simone
(Anfossi, S)
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA AEO-1609-2022
ANFOSSI, simone
0000-0001-5745-7587
Anfossi, Simone
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Anh, L. T.
(Anh, LT)
Cho Ray Hosp, Med Oncol, Ho Chi Minh City, Vietnam

[JCR상위 2.7] Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study SCIE 2.7 ONCOLOGY
Bar-Eli, Menashe
(Bar-Eli, M)
Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA

[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Bayraktar, Emine
(Bayraktar, E)
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
0000-0002-5189-1507
Bayraktar, Emine
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Bayraktar, Recep
(Bayraktar, R)
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
0000-0002-8227-2055
Bayraktar, Recep
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Bhattacharya, Rajat
(Bhattacharya, R)
Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA

[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
페이지 이동: